How Much Will Wegovy Cost in the UK?

Why Wegovy costs what it does: the honest market picture

Wegovy's price in the UK private market shifted significantly from late 2025. Eli Lilly's September 2025 list price increase on Mounjaro affected the broader GLP-1 conversation, but Novo Nordisk's pricing for Wegovy has also moved as demand has grown. As widely reported, the cost per pen at higher doses has risen materially over the past year, with private providers typically charging somewhere between £149 and £375 per month depending on which dose you're on.

The dose matters a lot here. Wegovy starts at 0.25mg and is titrated upward by your prescriber, through 0.5mg, 1mg, 1.7mg and up to the standard 2.4mg maintenance dose, with a newer 7.2mg option approved by the MHRA in April 2026 for adults with a BMI of 30 or above. If you're curious about how much weight you might lose on the 0.25mg starting dose, the evidence suggests this early stage is more about tolerance than transformation. So when you see a headline price, it's worth asking: which dose does that reflect?

NICE recommends semaglutide for weight management under NICE technology appraisal TA875, but NHS access is limited to specialist services with long waiting lists and strict criteria. For most people looking at private treatment right now, the relevant question is what a private prescription actually costs and what comes with it. The Wegovy pricing page goes into current figures in more detail.

What headline prices often leave out

A price for Wegovy isn't always a price for everything you need. Several costs are routinely excluded from the number shown in search results or on a provider's homepage.

Consultation fees are one. Some providers charge separately for the initial clinical review, sometimes £30 to £70 on top of the medicine cost. Others build it in. Prescription fees are another: writing and issuing a private prescription is a service, and not every provider absorbs that cost. Delivery charges vary too. And perhaps most importantly, aftercare is often absent from budget providers entirely, meaning that if you have a question, want to discuss a side effect or need a dose adjustment reviewed, there may be no structured route back to a clinician.

If you're comparing providers, the fairest approach is to add up consultation, prescription, treatment and delivery, then check what happens after you receive your first pen. That total is the actual cost. The Wegovy cost breakdown covers this in a format that makes comparison straightforward, and if you want a broader picture of what the evidence says about results, that's worth reading alongside the pricing question.

Where nume sits (and why we're transparent about not being the cheapest

One transparent price at nume covers your consultation, the clinical review (carried out by a GPhC-registered Independent Prescriber, personally) you can verify our pharmacy at GPhC registration 9012878), your prescription, your treatment, and free next-working-day delivery via DPD. Aftercare is available seven days a week, and every repeat order gets a fresh clinical review before it's approved. No subscription. No auto-renewal.

We don't position ourselves as the cheapest option on the market. That's a deliberate choice. The saving you'd get by going cheaper is typically made by trimming the clinical infrastructure, shorter or automated consultations, no structured aftercare, less rigorous identity and weight verification. Those aren't abstract differences; they affect whether treatment is safe and appropriate for you at every stage. A pen sitting in your fridge door is only useful if the dose inside it was prescribed by someone who properly assessed you.

There's no subscription model, no auto-renewal, and no obligation to continue. Current treatment pricing is shown clearly on our weight-loss treatments page. If you'd like to understand the clinical team behind the service, our lead prescriber's profile is there too.

Why 'cheapest' is the wrong test for a prescription medicine

For a prescription-only medicine like Wegovy, the lowest price answers the wrong question. The right ones are: was this prescribed following a proper clinical assessment? Is it coming from a licensed UK supply chain? And if something goes wrong, is there a clinician you can actually reach?

The MHRA has seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million in street value, including counterfeit pens that in some cases contained insulin rather than the stated medicine. The regulator's advice is clear: buy only from a pharmacy you can verify on the GPhC register, and be cautious of sellers offering these medicines without a prescription or at prices far below the market rate. Suspect sellers can be reported via the MHRA Yellow Card scheme.

Wegovy is also a medicine that requires ongoing clinical judgement, titration decisions, side-effect management, reassessment at each dose level, and if you're wondering how much weight loss to expect at the 1mg stage, that kind of question is exactly what a properly structured clinical review should help you answer. Cheap, disconnected supply doesn't support any of that. If you're ready to find out whether you're clinically suitable, the right starting point is a proper consultation, and it's also worth understanding whether Wegovy's price is likely to rise further before you decide when to begin. You can read more about how Wegovy works or go straight to start your free consultation with our prescribers today.